Micro-mechanical blood clot testing using smartphones - PubMed
- ️Sat Jan 01 2022
Micro-mechanical blood clot testing using smartphones
Justin Chan et al. Nat Commun. 2022.
Abstract
Frequent prothrombin time (PT) and international normalized ratio (INR) testing is critical for millions of people on lifelong anticoagulation with warfarin. Currently, testing is performed in hospital laboratories or with expensive point-of-care devices limiting the ability to test frequently and affordably. We report a proof-of-concept PT/INR testing system that uses the vibration motor and camera on smartphones to track micro-mechanical movements of a copper particle. The smartphone system computed the PT/INR with inter-class correlation coefficients of 0.963 and 0.966, compared to a clinical-grade coagulation analyzer for 140 plasma samples and demonstrated similar results for 80 whole blood samples using a single drop of blood (10 μl). When tested with 79 blood samples with coagulopathic conditions, the smartphone system demonstrated a correlation of 0.974 for both PT/INR. Given the ubiquity of smartphones in the global setting, this proof-of-concept technology may provide affordable and effective PT and INR testing in low-resource environments.
© 2022. The Author(s).
Conflict of interest statement
J.C., S.G., and K.M. are inventors on the provisional patent application in the process of being submitted by the University of Washington; J.C. is a co-founder of Wavely Diagnostics, Inc.; S.G. is a co-founder of Jeeva Wireless, Inc., Sound Life Sciences, Inc., and Wavely Diagnostics, Inc. The remaining authors declare no competing interests.
Figures

a Schematic of the system: a plastic attachment containing a cup with 10 μl of whole blood, 20 μl of tissue factor, and a copper particle. The smartphone’s vibration motor is coupled to the attachment and vibrates the particle, which is captured with the camera. b A workflow (from left to right) showing how whole blood is added to the cup in our system. c The phone captures the motion of the particle starting from when the tissue factor is added to the blood (tstart). The particle moves freely in the blood when it is in a liquid state. When the blood coagulates, the particle’s motion reduces (tend).

a Color thresholding and image processing techniques are applied to identify the cup holder and to create a mask that captures the motion of the capillary tube or pipette, Mtube,t. We then isolate the interior of the cup containing the particle, Mparticle,t. b The L1 norm is applied between masked images to quantify the amount of 2D motion between video frames. c The most prominent peak in the motion curve dtube[t] marks the start of the PT measurement, tstart. The knee of the particle’s motion curve dparticle[t] denotes the particle’s transition from motion to stasis, and marks the end of the PT measurement, tend.

a–d Correlation and Bland-Altman plots comparing plasma PT/INR values from the smartphone system and the clinical-grade coagulation analyzer. In the Bland-Altman plot, μ is the mean error and σ is the standard deviation (SD) of the errors, the solid line represents the mean error and the dotted lines represent the 95% limits of agreement. Source data are provided as a Source Data file.

a–d Correlation and Bland-Altman plots comparing coagulopathic plasma PT/INR values from the smartphone system and the clinical-grade coagulation analyzer. In the Bland-Altman plot, μ is the mean error and σ is the standard deviation (SD) of the errors, the solid line represents the mean error and the dotted lines represent the 95% limits of agreement. Source data are provided as a Source Data file.

a–d Correlation and Bland-Altman plots comparing whole blood PT/INR values from the smartphone system and the commercial POCT coagulometer. In the Bland-Altman plot, μ is the mean error and σ is the standard deviation (SD) of the errors, the solid line represents the mean error and the dotted lines represent the 95% limits of agreement. Source data are provided as a Source Data file.

The system was evaluated across (a) different vibration strengths, b different particle materials, c different smartphone models, d illuminance levels, and e, f different volumes of plasma in a small and large cup. The figure shows the mean and SD computed across three measurements. Source data are provided as a Source Data file.
Similar articles
-
Tripathi MM, Egawa S, Wirth AG, Tshikudi DM, Van Cott EM, Nadkarni SK. Tripathi MM, et al. Sci Rep. 2017 Aug 23;7(1):9169. doi: 10.1038/s41598-017-08693-5. Sci Rep. 2017. PMID: 28835607 Free PMC article.
-
Jonsson M, Hillarp A, Svensson P. Jonsson M, et al. Thromb Res. 2004;114(2):83-9. doi: 10.1016/j.thromres.2004.04.010. Thromb Res. 2004. PMID: 15306149
-
A Comparative Study of Point-of-Care Prothrombin Time in Cardiopulmonary Bypass Surgery.
Okabayashi S, Ogawa S, Tanaka KA, Nishiyama T, Takeshita S, Nakayama Y, Nakajima Y, Sawa T, Mizobe T. Okabayashi S, et al. J Cardiothorac Vasc Anesth. 2018 Aug;32(4):1609-1614. doi: 10.1053/j.jvca.2017.12.044. Epub 2017 Dec 29. J Cardiothorac Vasc Anesth. 2018. PMID: 29395816
-
Anticoagulation self-monitoring.
Pence C, McErlane K. Pence C, et al. Am J Nurs. 2005 Oct;105(10):62-5. doi: 10.1097/00000446-200510000-00036. Am J Nurs. 2005. PMID: 16205413 Review.
-
Home prothrombin time monitoring: a literature analysis.
Yang DT, Robetorye RS, Rodgers GM. Yang DT, et al. Am J Hematol. 2004 Oct;77(2):177-86. doi: 10.1002/ajh.20161. Am J Hematol. 2004. PMID: 15389909 Review.
Cited by
-
Telehealth and digital health innovations: A mixed landscape of access.
Phuong J, Ordóñez P, Cao J, Moukheiber M, Moukheiber L, Caspi A, Swenor BK, Naawu DKN, Mankoff J. Phuong J, et al. PLOS Digit Health. 2023 Dec 15;2(12):e0000401. doi: 10.1371/journal.pdig.0000401. eCollection 2023 Dec. PLOS Digit Health. 2023. PMID: 38100519 Free PMC article. Review.
-
Diagnosis and Prognosis of COVID-19 Disease Using Routine Blood Values and LogNNet Neural Network.
Huyut MT, Velichko A. Huyut MT, et al. Sensors (Basel). 2022 Jun 25;22(13):4820. doi: 10.3390/s22134820. Sensors (Basel). 2022. PMID: 35808317 Free PMC article.
-
Yang C, Yang Y, Zhao G, Wang H, Dai Y, Huang X. Yang C, et al. Biosensors (Basel). 2023 Jul 22;13(7):753. doi: 10.3390/bios13070753. Biosensors (Basel). 2023. PMID: 37504151 Free PMC article.
-
Update on Patient Self-Testing with Portable and Wearable Devices: Advantages and Limitations.
Lippi G, Pighi L, Mattiuzzi C. Lippi G, et al. Diagnostics (Basel). 2024 Sep 13;14(18):2037. doi: 10.3390/diagnostics14182037. Diagnostics (Basel). 2024. PMID: 39335715 Free PMC article.
-
Advances in Platelet-Dysfunction Diagnostic Technologies.
Yoon I, Han JH, Jeon HJ. Yoon I, et al. Biomolecules. 2024 Jun 17;14(6):714. doi: 10.3390/biom14060714. Biomolecules. 2024. PMID: 38927117 Free PMC article. Review.
References
-
- Fuster V, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur. Heart J. 2006;27:1979–2030. doi: 10.1093/eurheartj/ehl176. - DOI - PubMed
-
- MEPS-HC Data Tools ∣ AHRQ Data Tools, https://datatools.ahrq.gov/meps-hc?type=tab&tab=mepshcpd (2021).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical